Matchpoint Therapeutics
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Matchpoint Therapeutics is active in the biotechnology, medical, pharmaceutical space based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2021.
Within the biotechnology, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
The business is associated with Greater Boston Area, East Coast, New England, Northeastern US.
The company is listed at the Series_A stage of development.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $100M.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $100,000,000 |
Website: matchpointtx.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account